metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wn...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway
Rspo2-LGR4 agrava la progresión del carcinoma hepatocelular al activar la vía de señalización Wnt/beta-catenina
Yanghui Bia, Liping Zhangb, Yan Songc, Lijun Suna, Michael W. Mulhollandb, Yue Yind,
Corresponding author
yueyin@bjmu.edu.cn

Corresponding authors.
, Weizhen Zhanga,b,
Corresponding author
weizhenzhang@bjmu.edu.cn

Corresponding authors.
a School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China
b Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA
c First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
d Department of Pharmacology, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University, Beijing, China
Read
619
Times
was read the article
154
Total PDF
465
Total HTML
Share statistics
Article information
ISSN: 02105705
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 26 6 32
2024 November 51 9 60
2024 October 37 12 49
2024 September 29 24 53
2024 August 44 8 52
2024 July 48 23 71
2024 June 32 18 50
2024 May 41 25 66
2024 April 20 9 29
2024 March 17 10 27
2024 February 14 6 20
2024 January 11 0 11
2023 December 14 0 14
2023 November 11 0 11
2023 October 30 0 30
2023 September 13 0 13
2023 August 15 0 15
2023 July 12 4 16
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos